Pachygyria is a malformation of the brain’s surface in which the normal folds (gyri) are too few, too broad, and too flat, and the outer layer of brain tissue is abnormally thick. It results from a disruption in the way neurons migrate to their proper positions during fetal development, and it sits on a spectrum with complete smoothness of the brain (agyria) at one end and milder irregularities at the other. Most children with pachygyria develop seizures and some degree of intellectual disability, though severity varies widely depending on how much of the brain is affected and which genes are involved.
Where Pachygyria Fits on the Lissencephaly Spectrum
The term lissencephaly, meaning “smooth brain,” describes a range of cortical malformations caused by defective neuronal migration. That range runs from agyria, where the brain surface is essentially flat with no folds at all, through pachygyria, where a reduced number of broad, shallow folds are present, to subcortical band heterotopia, where a band of misplaced neurons sits beneath an otherwise partly normal cortex.1Journal of Pediatric Neurology. Lissencephaly, Pachygyrias, Band Heterotopias, RELN Pathway, and ARX Mutations (Incomplete Neuron Migration) Pachygyria can appear across a large portion of the brain (diffuse) or be confined to specific regions (focal), and the distinction has real consequences for a child’s symptoms and long-term outlook.
Because imaging alone cannot always distinguish pachygyria from other surface abnormalities, researchers have noted that a thick cortical ribbon on a scan does not guarantee the underlying tissue matches the classic pachygyria pattern. Some cases that look like pachygyria on MRI may correspond to different structural problems, such as polymicrogyria, where the folds are too many and too small rather than too few and too broad.2PubMed. The agyria-pachygyria complex: a spectrum of cortical malformations This overlap is one reason that genetic testing has become so central to reaching a precise diagnosis.
How It Happens During Fetal Development
In a normally developing brain, billions of neurons are born deep in the tissue lining the ventricles and then migrate outward in waves, guided by molecular signals, to build the six-layered cerebral cortex. This migration occurs mainly between roughly the seventh and twentieth weeks of gestation. When the process goes wrong during early stages, neurons fail to reach their intended positions, and the cortex ends up thick but disorganized, with too few layers and too few folds.
Classic work on the timing of these disruptions showed that the completely smooth agyric cortex corresponds to a migration failure around the 11th to 13th fetal week, while pachygyria likely arises from a somewhat later, less severe disturbance acting around or after the 13th week.3PubMed. Agyria-pachygyria (lissencephaly syndrome) The later the disruption, the more normal-looking cortical layers manage to form before things go wrong, which is why pachygyria generally falls on the milder end of the lissencephaly spectrum compared to complete agyria.
At the cellular level, the migration machinery depends heavily on the cytoskeleton, the internal scaffolding that neurons use to pull themselves along as they travel. Proteins encoded by genes like LIS1 and DCX help organize microtubules, which are the structural filaments that neurons ride during migration. When those proteins are defective, the whole transport system falters, leading to the broad, shallow folds characteristic of pachygyria.4PubMed Central. Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly
Genetic Causes
Roughly 80% of patients on the lissencephaly-pachygyria spectrum carry a mutation in one of two genes: LIS1 (also called PAFAH1B1) or DCX (doublecortin).5PubMed. The location of DCX mutations predicts malformation severity in X-linked lissencephaly The two genes produce different patterns of brain involvement, which has become a useful diagnostic clue.
LIS1 sits on chromosome 17 and was the first lissencephaly gene identified. Deletions of the chromosomal region containing LIS1 are the most common cause of classical lissencephaly.6JAMA. Lissencephaly: A Human Brain Malformation Associated With Deletion of the LIS1 Gene Located at Chromosome 17p13 Most patients with LIS1 mutations have severe malformations consisting of generalized agyria and pachygyria, with the back of the brain typically more affected than the front.7PubMed. LIS1 missense mutations cause milder lissencephaly phenotypes including a child with normal IQ However, milder missense mutations in LIS1 can produce much less severe outcomes, with at least one reported child having a normal IQ despite the malformation. The type of mutation matters: one study identified 31 different LIS1 mutations across affected patients, including nonsense, frameshift, missense, and splicing defects, each associated with varying degrees of cortical disorganization.8JAMA Neurology. LIS1-Related Isolated Lissencephaly: Spectrum of Mutations and Relationships With Malformation Severity
DCX is on the X chromosome, which gives it a distinctive sex-linked pattern. In males, who have only one X, DCX mutations typically cause lissencephaly or pachygyria concentrated in the front of the brain. In females, who have a second, normal copy of the gene on their other X chromosome, the same mutation more often produces subcortical band heterotopia, a milder form where a ribbon of misplaced neurons lies beneath a cortex that may look fairly normal on its surface.9PubMed. Familial pachygyria in both genders related to a DCX mutation That said, familial cases have been documented where both males and females in the same family developed pachygyria from the same DCX mutation, so the sex-linked pattern is not absolute.
Beyond LIS1 and DCX, a growing list of tubulin genes has been implicated. Mutations in TUBA1A, TUBB2B, TUBB3, TUBB5, and TUBG1 cause a group of conditions collectively called tubulinopathies. Among patients with complex cortical malformations, TUBA1A mutations are the most frequently detected in this group, found in over 40% of one large series, while TUBB2B and TUBB3 each accounted for a smaller share.10Brain. The wide spectrum of tubulinopathies: what are the key features for the diagnosis? The involvement of tubulin genes reinforced what researchers had suspected from the LIS1 and DCX findings: the microtubule transport system is the central vulnerability.11Trends in Genetics. Genetic mechanisms underlying abnormal neuronal migration in classical lissencephaly In large cohorts of patients with malformations of cortical development, tubulin mutations have been detected in somewhere between 1% and 13% of cases, suggesting that many other causative genes remain to be found.12Human Molecular Genetics. Recognizable cerebellar dysplasia associated with mutations in multiple tubulin genes
Nongenetic Causes
Not all pachygyria traces back to a gene mutation. Congenital cytomegalovirus (CMV) infection, one of the most common infections passed from mother to fetus, can disrupt neuronal migration if it strikes during the critical early weeks of brain development. In a study of nine children with proven congenital CMV, the timing of infection shaped the severity: those infected earlier tended to have lissencephaly or severe pachygyria, while later infections produced milder cortical irregularities or white-matter abnormalities.13PubMed. Malformations of cortical development in children with congenital cytomegalovirus infection – A study of nine children with proven congenital cytomegalovirus infection Other case reports have documented the lissencephaly-pachygyria spectrum in children with confirmed congenital CMV, with both CT and MRI showing marked migrational defects.14PubMed. Lissencephaly-pachygyria associated with congenital cytomegalovirus infection
This dual possibility, genetic or infectious, sometimes creates diagnostic ambiguity. One published case described a four-month-old girl who had both a positive urine test for CMV and a brain MRI showing lissencephaly. Genetic testing eventually revealed a pathogenic variant in PAFAH1B1 (the LIS1 gene), and the imaging lacked the calcifications and other hallmarks typical of CMV-related brain damage, suggesting the CMV was coincidental rather than causative.15PubMed Central. Infantile epileptic spasms syndrome in a child with lissencephaly associated with de novo PAFAH1B1 variant and coincidental CMV infection Cases like that illustrate why genetic workup is important even when an infectious cause seems plausible.
Symptoms and Severity
Seizures dominate the clinical picture. They occur in more than 90% of children with lissencephaly, and most children develop multiple seizure types, including infantile spasms, tonic seizures, focal seizures, and atonic episodes.16PubMed Central. Perampanel in lissencephaly-associated epilepsy In a series of 65 children with early-onset epileptic encephalopathy linked to pachygyria or lissencephaly, about half had pachygyria specifically, and the most common epilepsy syndrome was infantile spasms, followed by Ohtahara syndrome and early myoclonic encephalopathy.17Chinese Journal of Applied Clinical Pediatrics. Clinical features and genetic analysis of early-onset epileptic encephalopathy with pachygyria-lissencephaly
The extent of the brain involved is a strong predictor of how disabling the seizures become. In a follow-up study of children with diffuse agyria-pachygyria, 12 out of 13 who developed epilepsy had refractory (drug-resistant) seizures, mainly infantile spasms or Lennox-Gastaut syndrome. By contrast, among five children with focal pachygyria who had epilepsy, only one had refractory seizures, and the seizure pattern tended to be partial seizures with secondary generalization.18Chinese Journal of Applied Clinical Pediatrics. Analysis of the clinical features and electroencephalogram characteristics in 24 patients with agyria-pachygyria
Beyond seizures, most children with pachygyria experience significant developmental delays. Motor milestones such as sitting, crawling, and walking are often late or never fully achieved. Intellectual disability ranges from mild to profound depending on how widespread the malformation is. Feeding difficulties, low muscle tone in infancy, and spasticity that develops later are common. Some children have trouble swallowing and need nutritional support. Speech and language may be absent or severely limited in more affected individuals.
How Pachygyria Is Diagnosed
Brain imaging is the cornerstone. On both CT and MRI, the hallmarks of pachygyria are a thickened cortex, reduced white matter, and a brain surface with only a few broad, shallow folds. The boundary between gray and white matter tends to be smooth rather than following the normal interdigitating pattern.19PubMed. CT and MR imaging of pachygyria and agyria MRI is the preferred tool because it gives much better soft-tissue contrast and can show the thickness and layering of the cortex in detail.
In some cases, pachygyria can be suspected before birth. Prenatal ultrasound and fetal MRI can evaluate the development of brain folds at various stages of gestation by tracking the appearance of specific sulci and fissures. Familiarity with the normal timing of these landmarks is essential, because a brain that is simply too young to have developed a particular fold can look misleadingly smooth. Fetal MRI is considerably better than ultrasound at confirming cortical abnormalities. In one study comparing the two, ultrasound identified a gyral disorder in only 1 of 14 cases, while MRI suggested an abnormality in 8 of 9.20PubMed. Role of fetal ultrasound and magnetic resonance imaging in the prenatal diagnosis of migration disorders Prenatal imaging does carry the caveat that many folds do not appear until the late second or third trimester, so very early scans may not catch the problem.21PubMed. Prenatal US and MR imaging findings of lissencephaly: review of fetal cerebral sulcal development
Once imaging raises the suspicion of pachygyria, genetic testing is the next step. Standard approaches include chromosomal microarray to check for deletions (especially on chromosome 17), and sequencing of genes like LIS1, DCX, and the tubulin family. In cases where standard exome sequencing turns up empty, whole-genome sequencing has sometimes uncovered the answer. One case report described a Chinese infant with pachygyria whose trio whole-exome sequencing and copy-number-variation sequencing were both normal, but whole-genome sequencing revealed a novel inversion on chromosome 17 disrupting PAFAH1B1.22PubMed. Heterozygous inversion on chromosome 17 involving PAFAH1B1 detected by whole genome sequencing in a patient suffering from pachygyria Similarly, medical exome sequencing combined with specialized long-range PCR has been used to tease apart closely related tubulin genes, such as TUBB2A and TUBB2B, whose high sequence similarity can cause standard methods to miss the mutation.23PubMed. De Novo Mutated TUBB2B Associated Pachygyria Diagnosed by Medical Exome Sequencing and Long-Range PCR
Treatment and Management
No treatment can reverse the structural malformation itself. The cortex formed abnormally during fetal life, and there is no way to rewire it after the fact. Management focuses on controlling symptoms, particularly seizures, and on supporting development as much as possible.
Seizure control is the most pressing medical challenge. Most children with pachygyria-related epilepsy fail to become seizure-free on anti-seizure medications alone. The seizures commonly resist multiple drugs, and daily seizures place a heavy burden on both children and their families.16PubMed Central. Perampanel in lissencephaly-associated epilepsy Despite this, medication trials remain the first-line approach, and some newer anti-seizure drugs have shown promise in individual cases even when older medications had failed. The goal is usually meaningful reduction in seizure frequency rather than complete freedom.
For children with seizures arising primarily from one hemisphere, surgical options may be considered. Hemispherectomy, in which one hemisphere is disconnected or removed, has been studied in children with various developmental and acquired brain pathologies. In a series from Great Ormond Street Hospital in London, about half of children who underwent hemispherectomy became seizure-free, and roughly 90% across all pathology types achieved either seizure freedom or a greater than 75% reduction in seizures. Children with developmental pathology (a category that includes malformations like pachygyria) had a lower rate of complete seizure freedom, around 31%, but about 88% still had a worthwhile seizure outcome.24Brain. Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence Surgery this extensive is not appropriate for everyone, and it carries the cost of the neurological functions served by the removed hemisphere, but in carefully selected patients it can substantially reduce seizure burden.
Supportive therapies make up the other major pillar of management. In a study of patients with lissencephaly across several gene groups, families reported using a median of eight different supportive therapies per patient, with physiotherapy and respiratory therapy rated the most helpful.25Orphanet Journal of Rare Diseases. Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephaly Occupational therapy, speech therapy, and feeding support are commonly part of the care plan. Children with severe swallowing difficulties may need a gastrostomy tube. Orthopedic interventions or bracing may be required for spasticity and contractures that develop over time.
Long-Term Outlook
Prognosis depends heavily on how much of the brain is affected and what specific mutation is responsible. Diffuse agyria-pachygyria tends to carry a worse outlook than focal involvement, both in terms of seizure control and cognitive development. Children with complete agyria often have the most severe disabilities and shortest life expectancy, while some individuals with focal pachygyria may walk, communicate in limited ways, and live well into adulthood.
An interesting observation comes from a report of three adults with pachygyria, aged 28, 40, and 53, all of whom had severe neurological impairment and were wheelchair-dependent, but whose epilepsy had stabilized as they transitioned from childhood to adulthood. The authors raised the possibility that the long-term trajectory of pachygyria-related epilepsy may be better than clinicians initially assume, at least in some patients.26PubMed. Stabilized epilepsy in three adult cases of pachygyria Whether this stabilization reflects a genuine maturation-related change in seizure susceptibility or simply the natural history of certain milder malformations is unclear, but it offers a counterpoint to the bleak prognosis often delivered at the time of diagnosis.
Emerging Research in Gene Therapy for Cortical Malformation Epilepsy
One of the most active frontiers in this space is the development of gene therapy approaches to treat seizures arising from cortical malformations. Although still in preclinical stages, the concept is promising: rather than trying to fix the malformation itself, researchers are engineering viral vectors that deliver seizure-suppressing genes directly into the abnormal brain tissue. In a mouse model of focal cortical dysplasia, animals treated with a viral vector carrying an engineered potassium channel gene showed a roughly 87% decrease in seizure frequency once the natural worsening seen in control animals was taken into account. About 60% of treated animals became seizure-free by the end of the recording period.27Brain. Anti-seizure gene therapy for focal cortical dysplasia This type of approach is still years from human trials, and focal cortical dysplasia is not identical to pachygyria, but the shared problem of medication-resistant seizures arising from malformed cortex makes the research relevant. If gene therapy can quiet hyperexcitable neurons without requiring surgical removal of brain tissue, it would change the calculus for patients whose malformations are too widespread or too bilateral for traditional surgery.